MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Genomic Health Company Profile (NASDAQ:GHDX)

Consensus Ratings for Genomic Health (NASDAQ:GHDX) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Hold (Score: 2.44)
Consensus Price Target: $32.75 (23.12% upside)

Analysts' Ratings History for Genomic Health (NASDAQ:GHDX)
Show:
DateFirmActionRatingPrice TargetActions
5/26/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Jefferies GroupReiterated RatingHold$24.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016BarclaysLower Price TargetUnderweight$27.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Piper JaffrayReiterated RatingIn-Line$32.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Raymond JamesUpgradeMarket Perform -> Outperform$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015JMP SecuritiesBoost Price TargetOutperform$34.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2015Credit SuisseReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014Wells FargoInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014Bank of AmericaReiterated RatingBuy$28.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha